Synopsis All vertebrate embryos develop in the presence of maternally derived steroids, and maternal steroids have been hypothesized to link phenotype of the offspring to maternal physiology. In placental vertebrates, it is known that maternally derived steroids are metabolized during development via the sulfonation pathway. We used eggs from the red-eared slider turtle (Trachemys scripta) to determine whether the same metabolic pathway is used to metabolize maternally derived steroids in an oviparous vertebrate. To examine the relationship between estradiol and estrogen sulfates during development, levels of maternally derived estradiol were compared with levels of estradiol sulfate, estrone sulfate, and estriol sulfate at oviposition and after 20 days of embryonic development. Estrone sulfate was the only detectable estrogen sulfate. At oviposition, levels of both estradiol and estrone sulfate varied seasonally with clutches from later in the nesting season having significantly higher concentrations of both steroids. Levels of estrone sulfate increased during development, demonstrating that the sulfonation of maternally derived steroids occurs in oviparous vertebrates as well as in placental vertebrates. We also found that exogenous estrone sulfate increases the production of female hatchlings, thereby demonstrating the ability of this metabolite to influence embryonic development. To examine the role of sulfonation in the metabolism of maternal progesterone and testosterone, we characterized the metabolic fate of both steroids by applying tritiated forms of each steroid at oviposition and characterizing metabolites after 20 days of incubation. Similar to what was demonstrated for estradiol, both progesterone and testosterone are converted to sulfonated metabolites during embryonic development. These data suggest that steroid sulfates, both those that are maternally derived and those resulting from the metabolism of maternal steroids, are a key component of the mechanism underlying steroid-mediated maternal effects.
Introduction
For vertebrates, steroid signaling during embryonic development is thought to be essential for organizing the phenotype of the embryo. Embryos produce their own steroid signals and also encounter maternal steroid signals during development (Carere and Balthazart 2007) . In placental vertebrates, steroid levels during pregnancy are typically elevated relative to other periods in the life cycle (Pepe and Albrecht 1995) . The placenta possesses a number of steroidogenic enzymes that modulate maternal steroid signals as they pass through, thereby regulating embryos' exposure to maternal steroids (Conley and Mason 1990; Pepe and Albrecht 1995) . Similarly, in oviparous vertebrates, embryos begin development in an egg environment that frequently contains steroid concentrations higher than those observed in maternal circulation (Carere and Balthazart 2007) . Recent work on reptiles ) and birds (von Engelhardt et al. 2009; Paitz and Casto 2012) suggests that maternally derived steroids are also subject to metabolism early in development. The metabolism of maternally derived steroids appears to be integral for the regulation of the early endocrine environment both in placental and oviparous vertebrate embryos.
Integrative and Comparative Biology Integrative and Comparative Biology, volume 53, number 6, pp. 895-901 doi:10.1093/icb/ict027 Society for Integrative and Comparative Biology There is ample evidence that maternally derived steroids can influence phenotypic variation in oviparous species (Groothuis and Schwabl 2008; Gil 2008 ), but we lack a clear understanding of how these maternal effects are realized in the face of embryonic regulation of the endocrine environment. Similar metabolic pathways appear to be present in birds and reptiles as testosterone (von Engelhardt et al. 2009; ), corticosterone (von Engelhardt et al. 2009 ), and progesterone (Paitz and Casto 2012) all are converted to water-soluble metabolites in ovo during the first few days of development. In the red-eared slider turtle (Trachemys scripta), we know that levels of maternally derived progesterone, testosterone, and estradiol decline to low/undetectable levels prior to the beginning of gonadal differentiation (Paitz and Bowden 2009) .
We have previously reported that the application of estradiol sulfate to eggs immediately after oviposition increases the production of female offspring in much the same manner as does estradiol itself (Crews et al. 1996; . While that study demonstrated that steroid sulfates can influence the phenotype of the offspring, whether steroid sulfates are formed from endogenous maternal steroids is presently unknown. Here we characterize the metabolism of endogenous estradiol present in the yolk of T. scripta eggs at oviposition, taking advantage of the natural variation in levels of maternally derived estradiol when a female's second clutch contains approximately 10Â the estradiol as her first clutch within a nesting season (Paitz and Bowden 2009) . Using this variation, we test whether levels of estradiol at oviposition are related to levels of estrogen sulfate at the onset (day 20) of gonadal differentiation, which in this species comprises the middle third of embryonic development (Wibbels et al. 1991) . We predicted that clutches with higher initial estradiol levels would have higher levels of estrogen sulfates later in development. We also examined the effect of exogenously applied estrone sulfate on sex determination to test the hypothesis that estrogen sulfate is capable of influencing phenotypic variation. Additionally, we characterized the metabolic fate of tritiated progesterone and testosterone applied to eggs at oviposition and incubated for 20 days to determine whether the metabolic pathways for conversion are conserved among several steroid hormones during development.
Methods

Quantifying estradiol
Ten clutches of T. scripta eggs were collected from gravid females inhabiting Banner Marsh State Fish and Wildlife Area (Fulton Co., IL, USA) during the summer of 2011 (IDNR permit NH11.2084 , IACUC protocol 04-2010 . Capitalizing on the seasonal variation in levels of maternally derived estradiol (Paitz and Bowden 2009) , five clutches were collected early in the nesting season (25 May to 6 June) and five clutches were collected late in the nesting season (20) (21) (22) (23) (24) (25) (26) . Within 24 h of oviposition, one egg from each clutch was randomly sampled to characterize initial steroid levels. The remaining eggs were incubated on moist vermiculite at 318C. After 20 days of incubation, one egg from each clutch was sampled to measure estrogen sulfate levels. All other eggs were designated to an unrelated study. At the time of sampling, eggs were separated into yolk, extraembryonic fluid, and embryo components and frozen until quantification of steroids. For day 0 eggs, the extraembryonic fluid was exclusively albumen while the extraembryonic fluid from day 20 eggs was still primarily albumen but also contained some amniotic fluid.
Using a previously described radioimmunoassay (RIA) technique (Wingfield and Farner 1975; Bowden 2008, 2009 ), levels of maternally derived estradiol were quantified in the yolk of eggs sampled just after oviposition. Estradiol was extracted from 50 mg of yolk using a 70:30 combination of diethyl ether:petroleum ether and fractionated using column chromatography. Recoveries were calculated with the addition of a 2000 cpm tracer of estradiol that was initially added to each sample. The estradiol fraction (40% ethyl acetate in isooctane) was then quantified via RIA (Antibody 7010, Biogenesis, Kingston, NH, USA) in duplicate and compared with a standard curve that ranges from 5 to 750 pg/g.
Quantifying estrogen sulfates
To quantify estrogen sulfates, we used extraembryonic fluid because a previous study of this species demonstrated that the highest concentrations of water-soluble metabolites of estradiol were found there . One milliliter of extraembryonic fluid was added to 3 ml methanol, vortexed, stored at À208C overnight, and then spun at 2000 rpm to pellet precipitated proteins. The supernatant was poured into a new test tube and the pellet was resuspended in 2 ml of fresh methanol, vortexed, centrifuged, and this supernatant added to the previous supernatant. The combined supernatant was dried under nitrogen gas and suspended in 5 ml of nano-pure water. For each sample, two Seppak cartridges (C18 plus short cartridge, 55-105 mm particle size; Waters, Milford, MA) were attached, charged with 5 ml methanol followed by 5 ml nanopure water, and the samples were then loaded onto the cartridges. Free steroids were eluted from the cartridges with 5 ml diethyl ether and the sulfate fraction was eluted with 5 ml methanol . The methanol eluate containing the estrogen sulfates was dried under nitrogen gas. Additionally, nine extraembryonic fluid samples were spiked with one of three amounts (5.0, 2.5, or 0.5 ng) of estradiol sulfate, estrone sulfate, and estriol sulfate, respectively (Steraloids, Newport, RI), prepped in the same manner, and used to calculate percent recovery for this technique.
We used liquid chromatography/tandem mass spectrometry (LC/MS/MS) to quantify three estrogen sulfates (estradiol sulfate, estrone sulfate, and estriol sulfate) in the extraembryonic fluid of eggs sampled both at oviposition and at incubation day 20. The LC/MS/MS analysis was performed in the Metabolomics Center at the University of Illinois at Urbana-Champaign with a 5500 QTRAP mass spectrometer (AB Sciex, Foster City, CA) equipped with a 1200 Agilent HPLC. Analyst (version 1.5.1, Applied Biosystems) was used for data acquisition and processing. The HPLC flow rate was set at 0.35 ml/min. HPLC mobile phases consisted of 0.1% formic acid in water (A) and 0.1% formic acid in acetonitrile (B). The autosampler was kept at 58C. The injection volume was 5 ml. An Agilent Zorbax SB-Aq column (3.5 mm, 50 Â 4.6 mm) was used for the separation with the following gradient: 0-2 min, 80% A; 6-10 min, 25% A; 11-16.5 min, 80% A. The mass spectrometer was operated under negative-mode electrospray ionization. The electrospray voltage was set to À4500 V, the heater was set at 6008C, the curtain gas was 35, and GS1 and GS2 were 50 and 65, respectively. Quantitative analysis was performed via MRM where m/z 349.1 ! m/z 269.1 (3-OL-17-one; estrone-sulfate); m/z 351.1 ! m/z 271.1 (17-b estradiol; estradiol-sulfate); and m/z 367.1 ! m/z 287.1 (16--17-b-estriol; estriol-sulfate) were monitored. Values were compared with a standard curve that had concentrations ranging from 0.08 to 1.0 ng/ml.
Application of exogenous estrone sulfate
Upon identifying estrone sulfate as the only detectable estrogen sulfate, we conducted a follow-up study to examine the effect of this metabolite on sex determination. We used an experimental design similar to one we previously used for examining the biological activity of estradiol sulfate . In the summer of 2012 (30 May to 1 June), 13 clutches of eggs were collected as described above (IDNR permit NH12.2084 , IACUC protocol 04-2010 . Eggs from each clutch were randomly divided into four groups that received one of four topically applied doses (0, 0.1, 1.0, or 10 mg) of estrone sulfate dissolved in 5 ml of 70% ethanol within 24 h of oviposition. Eggs were then incubated at 288C (a male-biased temperature) for the entirety of development and sex was determined by macroscopic inspection of the gonads after a minimum of 60 days after hatch .
Metabolism of progesterone and testosterone
The metabolic fate of progesterone and testosterone was characterized using the same techniques previously used to identify the metabolic fate of estradiol . Briefly, three clutches of T. scripta eggs were collected as described above. Within 24 h of oviposition, half of the eggs from each clutch were treated with 300,000 cpm of tritiated progesterone (NET-381, Perkin Elmer, Boston, MA) or 100,000 cpm of tritiated testosterone (NET-553, Perkin Elmer) dissolved in 5 ml of 70% ethanol. All eggs were incubated at 318C for 20 days when they were frozen until characterization of the metabolites.
To characterize metabolites, eggs (two eggs/clutch/ steroid) were separated into embryo (including extraembryonic membranes), yolk, and extraembryonic fluid. Each component was homogenized and the radioactivity partitioned between an organic phase and an aqueous phase using diethyl ether and water to initially characterize the distribution of the radioactivity within the egg ). Because of the high levels of water-soluble radioactivity within the extraembryonic fluids for both steroids after 20 days of development, metabolites within this component were characterized by thinlayer chromatography (TLC). First, metabolites were separated into glucuronide, sulfate, and free fractions (Safarty and Lispett 1966; . Second, the metabolites within the sulfate fraction were subjected to acid solvolysis to return the steroid sulfates to their parent form (BenowitzFredericks et al. 2005; ) and then separated via TLC to characterize metabolites within the sulfate fraction.
Statistical analysis
Steroid concentrations were log-transformed prior to analysis. To test for seasonal variation in initial estradiol levels, we used analysis of variance (ANOVA) that contained season (early versus late) as a fixed factor. To test for seasonal variation in estrone sulfate as well as changes over the first 20 days of development, we used an ANOVA that contained season (early versus late), sampling period (day 0 versus day 20), and their interaction as fixed factors. Sample size precluded us from including clutch as a random factor, but each clutch was represented Sulfonation of maternal steroids 897 evenly, making it unlikely that differences among clutches are driving any differences attributed to season or sampling period. To compare sex ratios between the different doses of estrone sulfate, Fisher's exact tests were used. All analyses were conducted using SAS v. 9.3 (Cary, NC, USA). (Fig. 1) . As with estradiol, late-season clutches contained higher concentrations of estrone sulfate at oviposition, while concentrations of estrone sulfate were higher after 20 days of incubation both in early and in lateseason clutches.
Results
Levels of estradiol and estrone sulfate
Effect of estrone sulfate on sex determination
Exogenous estrone sulfate had a highly significant effect on sex ratios of hatchlings (P50.001) with the control and lowest dose resulting in 97% and 98% males, respectively, while the two highest doses produced 100% females (Fig. 2) .
Metabolic fate of progesterone and testosterone
After 20 days of incubation, we recovered 62% and 58% of the applied radioactivity for progesterone and testosterone, respectively (Table 1) . For progesterone, 96% of the recovered radioactivity was water-soluble. For testosterone, 89% was water-soluble (Table 1) . When separated by TLC, all water-soluble metabolites (of both progesterone and testosterone) within the extraembryonic fluid were detected within the sulfate fraction of the plate . The water-soluble sulfate fraction was then subjected to acid solvolysis to further characterize the metabolites formed. TLC separation of the ether-soluble metabolites freed by acid solvolysis suggests that both progesterone and testosterone are converted to more polar metabolites prior to sulfonation as these newly freed metabolites migrated more slowly than did the progesterone and testosterone Note: Each value represents the mean of three eggs initially treated with 100,000 cpm of testosterone or 300,000 cpm of progesterone, respectively. EE, extraembryonic. standards. At present, the identity of these metabolites is unknown.
Discussion
Several important findings regarding the fate of maternally derived steroids and of the phenotypes of offspring come from this study. Estrone sulfate is the primary estrogen sulfate in T. scripta eggs and is present at oviposition. Levels of maternally derived estrone sulfate vary seasonally with lateseason clutches having higher concentrations. Levels of estrone sulfate increase over the first 20 days of incubation, and exogenous estrone sulfate is capable of influencing sex determination. These findings demonstrate that there is variation in maternally derived levels, that concentrations increase during development, and that variation in steroid sulfates (via exogenous manipulation in this case) can lead to phenotypic effects. Furthermore, other maternally derived steroids, including progesterone and testosterone, are subject to sulfonation in ovo, highlighting a potentially important role for steroid sulfates in mediating maternal effects.
Demonstrating that endogenous levels of maternal steroids are related to metabolites later in development provides an important advance in our mechanistic understanding of how steroid-mediated maternal effects arise in oviparous vertebrates. The in ovo metabolism of exogenous steroids has been demonstrated in a number of reptiles ) and birds (von Engelhardt et al. 2009; Paitz and Casto 2012) but the metabolic fate of the steroids in endogenous yolk remained to be elucidated. The conversion of estradiol to estrone sulfate may actually facilitate movement to the embryo as estradiol is lipophilic in nature and would be unlikely to passively diffuse from the yolk to the embryo (Moore and Johnston 2008) . Estrone sulfate is more hydrophilic in nature, and a previous study of T. scripta demonstrated that estrogen sulfates can be taken up by the embryo during development . Upon uptake, estrone sulfate would most likely need to be converted back to estrone by the enzyme steroid sulfatase, as estrogen sulfates are not known to serve as ligands for estrogen receptors (Pasqualini et al. 1986 ). While demonstrating a relationship between maternal estradiol and estrone sulfate in an oviparous vertebrate is novel, more work is needed to determine whether the effects of estrogen sulfates are direct or the result of sulfates serving as precursors for the production of steroids such as estrone or estradiol (Fig. 3) .
Additionally, it remains to be determined which maternal steroids may contribute to the pool of estrone sulfate detected after 20 days of incubation since presumably a number of steroids could ultimately be converted to estrone sulfate. The levels of estradiol present at oviposition are not high enough to account for the increase in concentrations of estrone sulfate. Fig. 4 The timing and localization of maternally derived estradiol throughout development in Trachemys scripta based on data from . While estradiol levels in the yolk decline during the first third of embryonic development, there is a corresponding increase in the levels of estrone sulfate in yolk and albumen, suggesting that yolk estradiol is subjected to phase I and phase II metabolism. During the temperature-sensitive period (TSP), estrone sulfate levels slowly decline in the yolk and albumen compartments, while there is a corresponding increase in levels of estrone sulfate in the embryo. The TSP is the period during which sex is determined in T. scripta. Following the TSP, levels of estrone sulfate decline more rapidly in the yolk and albumen while they increase in the embryo, most likely due to the increased rate at which yolk and albumen are incorporated into the rapidly growing embryo, suggesting that maternal steroids may also have effects in the later portion of development. Fig. 3 Conversion of maternally derived estradiol during development in Trachemys scripta based upon data from and the present study. Estradiol that is present in the yolk at oviposition is rapidly subjected to phase I metabolism, resulting in the formation of estrone, which in turn is subjected to phase II metabolism, thereby forming estrone sulfate. Both are enzymatically reversible reactions as indicated by the black arrows. At present, it is unclear which, or if all, products actually produce biological effects such as sex reversal.
It is becoming increasingly clear that early embryonic development is a dynamic period endocrinologically in oviparous vertebrates, with steroids of maternal origin being metabolized and moved throughout the egg von Engelhardt et al. 2009; . In T. scripta, we are amassing considerable information on the metabolism and movement of estrogens, starting with the early decline of estradiol in the yolk such that estradiol is no longer detectable after day 15 of development (Paitz and Bowden 2009) . We now know that this decline is due to the conversion of estradiol to a variety of water-soluble estrogen sulfates, including estrone sulfate, which reside in the yolk and extraembryonic fluid until later in development when they are taken up by the embryo at approximately the same rate that yolk and extraembryonic fluid are converted to embryonic tissue Fig. 4) . We can now add the early metabolism of progesterone and testosterone to this picture and present a general model for how steroids are processed during early embryonic development (Fig. 5) . Our data solidify sulfonation as a primary metabolic pathway for maternally derived steroids Bowden 2008, 2011; .
Ultimately, the sulfonation of maternal steroids appears to be a key component in the regulation of the embryonic endocrine environment of vertebrates. The sulfonation of maternal steroids has long been recognized as a vital regulator of maternal steroids by the ''fetoplacental unit'' in placental vertebrates (Diczfalusy 1964) . The general consensus from this work is that the sulfonation of maternal steroids serves to buffer the developing fetus from the abundance of active steroids present in the maternal circulation. For both placental and oviparous vertebrates, the sulfonation of maternal steroids may serve to buffer some steroid-sensitive developmental processes (such as sexual differentiation of the brain) (Carere and Balthazart 2007) from the effects of maternal steroids while other processes may be influenced by maternal signals in the form of steroid sulfates.
The next challenge is to elucidate how the interplay between maternal steroids and embryonic metabolism results in the wide variety of maternal effects observed in oviparous species. In particular, identification of critical developmental periods for maternal effects, coupled with a detailed understanding of which metabolites are present, as well as the potential for biological effects to be elicited by those compounds, is needed. Given that we report movement of estrogen metabolites throughout development, but that movement into the embryo primarily occurs later in development, steroids present at oviposition may be able to influence embryonic processes across development, including those that occur during the final stages of development. The sulfonation of several maternally derived steroids creates a scenario in which the expression of steroid sulfatase could modulate when and where these steroid sulfates are returned to their active form. Despite a number of unanswered questions, our current understanding of the physiological mechanism underlying the effects of maternal steroid highlights the fact that embryos are not simply passive responders to the levels of steroids present in eggs. Under this model, all steroids present at oviposition would be subjected to phase I and phase II metabolism, with the potential back conversion by enzymatic conversion. Biological effects could potentially result from several different products within the pathway and at various points during development.
